Pacira Pharmaceuticals, Inc. Reports Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Pacira Pharma (PCRX) Tops Q2 EPS by 16c
August 4, 2016 7:39 AM EDTPacira Pharma (NASDAQ: PCRX) reported Q2 EPS of $0.19, $0.16 better than the analyst estimate of $0.03. Revenue for the quarter came in at $69.6 million versus the consensus estimate of $67.8 million.
For earnings history and earnings-related data on Pacira Pharma (PCRX) click here.
... More


